CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.8003
-0.0354 (-4.24%)
Jan 28, 2026, 12:07 PM EST - Market open
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $9.24 million as of January 28, 2026. Its market cap has decreased by -65.05% in one year.
Market Cap
9.24M
Enterprise Value
7.79M
1-Year Change
-65.05%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $9.24M, a decrease of -79.97%. That is a compound annual growth rate of -43.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 9.64M | -37.40% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TransCode Therapeutics | 11.32M |
| Phio Pharmaceuticals | 11.20M |
| Chemomab Therapeutics | 10.83M |
| GridAI Technologies | 10.42M |
| PharmaCyte Biotech | 10.03M |
| BioRestorative Therapies | 9.94M |
| Pulmatrix | 9.28M |
| BioVie | 9.27M |